Allurion prices $20M public offering and $2.7M private placement with RTW

ALLURION TECHNOLOGIES, INC.

Public offering of 14.4M shares + warrants at $1.20/share for $17.3M gross; underwriters have 30-day option for 15% more.
Concurrent private placement: $2.7M to RTW for Series A convertible preferred stock and warrants, subject to stockholder approval.
Total gross proceeds ~$20M before expenses; net proceeds to fund clinical trials, sales, R&D, and working capital.
Closed July 1, 2024; RTW is a significant stockholder and also bought in the public offering (limited to 1% of outstanding).
Series A Preferred Stock non-voting, auto-converts to common upon stockholder approval; mandatory redemption by Dec 31, 2026.

item 1.01 item 5.03 item 3.02 item 8.01 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.